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To the Editor: 25 
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We have previously shown in a cohort of asthmatic patients that impulse 27 
oscillometry (IOS) and spirometry are equally useful in predicting asthma 28 
control as  assessed by prescriptions of oral corticosteroid and inhaled 29 
albuterol using health informatics1. These were patients referred from primary 30 
care for screening into clinical trials. We wanted to know how IOS and 31 
spirometry were related to the asthma control questionnaire (ACQ) in a real 32 
life secondary care clinic setting. In particular we were interested to see if IOS 33 
outcomes reflecting frequency dependent heterogeneity 2, namely the 34 
difference in resistance at 5Hz and 20Hz (R5-R20) and the reactance area 35 
(AX) between 5Hz and the resonant frequency (RF), are more closely 36 
associated with worse asthma control ,as has previously been described in 37 
children with asthma3.  38 
We have evaluated a separate series of 108 unselected patients attending a 39 
National Health Service (NHS) asthma secondary care clinic, who completed 40 
an ACQ-5 score 8 in addition to having spirometry and IOS, as part of their 41 
usual care. Their current asthma therapy at the time of the clinic visit was also 42 
documented. We routinely perform IOS, spirometry and ACQ in our clinic, 43 
hence this audit of usual clinical care did not require ethics approval, although 44 
Caldicott guardian approval was obtained in order to allow appropriate access 45 
to the patient identifiable NHS data .IOS (Jaeger Masterscreen, Hochberg 46 
Germany) and spirometry (Micromedical Chatham Kent, UK) were performed 47 
in triplicate according to European Respiratory Society guidelines. 48 
3 
We analysed the IOS and spirometry data according to both ACQ-5 and 49 
current salbutamol use comparing predefined cut-off values for each 50 
measurement as follows: FEV1 <80 % versus ≥80 % predicted; FEF25–75 <50 51 
% versus ≥50% predicted; FEV1/FVC ratio <0.70 versus ≥0.70; R5 < 150 % 52 
versus ≥150 % predicted; R20 <150% versus ≥150% predicted, R5–R20 < 0.1 53 
versus ≥0.1 kPa/l.s (i.e. 1 cmH2O/l.s); AX <0.8 versus ≥ 0.8 kPa/l (i.e. 8 54 
cmH2O/l), RF (resonant frequency) <15 versus ≥ 15Hz. Comparisons for each 55 
outcome were made by unpaired Students t tests with alpha error set at 0.05 56 
(two tailed). 57 
The patients (n=108) had an overall mean age of 42 years, FEV1 of 81% 58 
predicted, FEV1/FVC of 0.68, R5 of 178 % predicted,R5-R20 of 0.16 kPa/l.s 59 
and ACQ-5 score of 2.37. All patients were receiving inhaled corticosteroids 60 
(ICS) in a median beclomethasone equivalent dose of 800 µg/day, 80% were 61 
taking long acting beta-agonists (LABA) and 36% were taking leukotriene 62 
receptor antagonists. 63 
The results showed that  IOS measurements of R5-R20, AX and RF, but none 64 
of the spirometry measurements were significantly different in terms of worse 65 
control as ACQ-5 (Table and Figure), while only R5-R20 was significantly 66 
different for increased salbutamol use: 5 vs 8 puffs /day (P=0.006). 67 
Furthermore when the data were analyzed using lower cut-off values for 68 
FEV1/FVC ratio (<0.6 and <0.5) and FEF25-75 (<40% and <30% predicted) 69 
there were also no significant differences in ACQ-5 . 70 
Our data would therefore suggest that in a real life clinic setting IOS rather 71 
than spirometry is more closely related to asthma control based on the ACQ-5 72 
score. Overall our patients had moderate to severe persistent asthma in 73 
4 
keeping with a high total airway resistance (R5) of 178% and mean ACQ 74 
score of 2.374. Indeed the lower bound of the 95%CI for ACQ was higher than 75 
the cut off value of 1.5 for poorly controlled asthma for variables, even in 76 
those patients with a preserved FEV1 ≥ 80% (Figure). Pointedly the ACQ 77 
score has been shown to be a highly predictive proxy for the future risk of 78 
asthma exacerbations5.  79 
The R5-R20 and AX are indicative of  frequency dependent heterogeneity for 80 
respiratory resistance and reactance respectively throughout the lung 2. We 81 
were not able to measure resistance or reactance at frequencies <5Hz which 82 
might better reflect smaller airways . Our patients had evidence of large 83 
airway obstruction as reflected by a mean FEV1/FVC ratio of 0.68 and a mean 84 
FEV1 of 81% predicted  . As such our data would suggest that IOS is a more 85 
sensitive index of airway obstruction than spirometry irrespective of the site of 86 
obstruction at least in patients with mild to moderate persistent asthma  . 87 
Nonetheless we observed that neither R5 (reflecting total airway resistance) 88 
nor R20 (reflecting central airway resistance) were associated with a 89 
significant difference in ACQ, in contrast to the significant difference seen with 90 
R5-R20 . Our data are similar to those of Shi et al. where the heterogeneity of 91 
resistance (R5-20) or reactance (AX) were more predictive of asthma control 92 
than either R5 or X5 in asthmatic children3 . However in a cohort of patients 93 
with no evidence of large airway obstruction who had a preserved FEV1>80% 94 
,an abnormal R5-R20 was associated with increased use of oral corticosteroid 95 
and albuterol 6. 96 
We did not however observe a significant difference with ACQ in relation to 97 
FEF25-75 which is a rather variable volume dependent measurement of flow 98 
5 
rate 7. Indeed even when using a lower cut off value <30 % predicted for 99 
FEF25-75 there was still no significant difference in ACQ score. IOS is 100 
considered to be more physiological than spirometry as it is performed during 101 
normal quiet breathing and therefore not affected by forced expiratory 102 
changes which occur during spirometry2. The present data differ from our 103 
previous observations1 where we found that IOS and spirometry measures 104 
were equally useful as markers of asthma control using prescribing data for 105 
oral corticosteroid and inhaled albuterol use. This may be explained by the 106 
patients actually recording their ACQ score in the clinic at the same time as 107 
having their pulmonary function performed, perhaps resulting in a greater 108 
degree of concordance between physiology and symptoms. We elected to 109 
use the abbreviated ACQ-5 score because we did not want to confound the 110 
results by including FEV1% or albuterol use. Moreover it has been shown that 111 
the abbreviated ACQ-5 score is as sensitive as the ACQ-7 score8. 112 
In conclusion impulse oscillometry outcomes reflecting frequency dependent 113 
heterogeneity appear to be more closely related to asthma control than 114 
spirometry in patients with moderate to severe persistent asthma . Further 115 
prospective trials are indicated to assess whether serial long term IOS 116 
measurements may help guide decision making for patients with persistent 117 
asthma with disproportionate small airways disease, especially since health 118 
economics studies have suggested that using extra fine particle inhalers 119 
containing ICS inhalers may confer better long term outcomes9. 120 
121 
122 
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Figure 1. 
Figure Legend 
Mean and 95% CI for  ACQ5 score when stratified for both IOS and spirometry cut off values 
.Interrupted lines denote cut off values for ACQ score for  well controlled (<0.75) and poorly 
controlled asthma (≥1.50 ).Values for R5-R20 are kPa/l.s and AX are kPa/l , FEV1 and 
FEF25-75 are % predicted 
R
5
-R
2
0

0
.1
R
5
-R
2
0
<
0
.1
A
X

0
.8
A
X
<
0
.8
F
E
F
2
5
-7
5
<
5
0
%
F
E
F
2
5
-7
5

5
0
%
F
E
V
1
<
8
0
%
F
E
V
1

8
0
%
0
1
2
3
4
A
C
Q
5
p = 0 .0 1 p = 0 .0 2 p =  0 .5 7 p =  0 .0 9
0 .75
1 .5
Figure No. 1 - Unmarked
Click here to download Figure No. - Unmarked: Manuscript JACI Figure 1.docx
Manuscript JACI-D-15-01438: Utility of impulse oscillometry in patients with moderate 
to severe persistent asthma 
Table 1. Pulmonary function measures in relation to ACQ5 score 
ACQ5 n ACQ5 n p value 
Impulse oscillometry 
R5-R20 
(kPa/L.s)
<0.1 ≥0.1 0.01 
2.03 (0.17) 46 2.62 (0.15) 62 
R5 
(% pred)  
<150% ≥150% 0.18 
2.18 (0.17) 42 2.49 (0.15) 66 
R20 
(% pred) 
<150% ≥150% 0.30 
2.50 (0.15) 51 2.26 (0.17) 57 
AX 
(kPa/L)
<0.8 ≥0.8 0.02 
2.08 (0.17) 38 2.74 (0.21) 41 
RF 
(Hz) 
<15 ≥15 0.04 
2.06 (0.20) 31 2.65 (0.19) 48 
Spirometry 
FEV1
(% pred)
<80% ≥80% 0.09 
2.59 (0.19) 47 2.20 (0.14) 61 
FEV1/FVC 
(Ratio) 
<0.7 ≥0.7 0.49 
2.29 (0.17) 55 2.45 (0.16) 53 
FEF25-75
(% pred)
<50% ≥50% 0.57 
2.43 (0.17) 59 2.30 (0.15) 49 
Data for AX and RF were only available in a subgroup of n=79 patients, while all other 
variables were on the full dataset of n=108 .Values for ACQ-5 are means (SEM). 
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